UNSPSC 51381508: Tolmetin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H15NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D8K2JPN18B, chemically known as 1h-pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)- but generally known as tolmetin, which bears US NIH Compound Identifier 5509. European Medicines Agency schedules Tolmetin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11162MIG.

UNSPSC 51381508 Tolmetin, a Commodity code, nominally covers a nonsteroidal anti-inflammatory drug product; however, recent state and local procurement activity under this code does not reflect pharmaceutical purchases of tolmetin itself. The single recent opportunity — Seminole County, Florida's IFB60459723LAS — solicits naloxone and drug deactivation systems, a scope misaligned with the code's stated commodity. Tolmetin procurement activity does not appear in recent state and local contracting records, and the code shows little relevant recent activity targeting the pharmaceutical supply it nominally represents.

Seminole County, Florida posted the only recent opportunity on June 30, 2026, with a due date of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding (IFB). The procurement specifies quarterly deliveries to the Seminole County Community Health Building in Sanford, with all shipping and delivery costs included in vendor proposals, and includes a two-year initial term with a one-year renewal option. Vendors must comply with drug-free workplace certification, E-Verify requirements, and insurance coverage minimums, including workers' compensation and commercial general liability. The mismatch between the code's nominal pharmaceutical scope and the actual opportunity sourced suggests either a tagging error in the state procurement system or that tolmetin does not currently drive measurable state and local demand.